Raptor Pharmaceuticals

Biotechnology ResearchUnited States51-200 Employees

Raptor Pharmaceutical Corp. is a global biopharmaceutical company focused on the development and commercialization of life-altering therapeutics that treat rare, debilitating and often fatal diseases. The company is engaged in multiple therapeutic areas such as nephropathic cystinosis, Huntington’s disease (HD), and mitochondrial diseases including Leigh’s syndrome. Raptor holds several orphan drug designations, including orphan drug exclusivity for nephropathic cystinosis in the U.S. and EU, and orphan drug designation for HD in the U.S. and EU. Raptor holds intellectual property for the use of cysteamine in HD and other neurodegenerative disorders including Parkinson’s disease and Rett syndrome. We are headquartered in Novato, CA, and are always looking for innovative and passionate individuals to join our team! For additional information about the company, or if you are interested in a career at Raptor, please visit our website: http://www.raptorpharma.com

Sign up for free to view info

Email Format Employee directory